GlassScriptPhysician profile
Anthony T Lam
NPI 1184185431
$1,643.68
in general payments reported to CMS, 2019-2025
23 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $155 · 2020: $30.28 · 2022: $304 · 2023: $232 · 2024: $466 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,154.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $367.18 | 2023-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Graftguide |
| Ethicon US, LLC | $265.07 | 2022-2025 | Echelon Flex, Vistaseal, Evarrest |
| Medical Device Business Services, INC. | $231.51 | 2022-2024 | Xcm Biologic Tissue Matrix |
| Csl Behring | $125.00 | 2019 | |
| Depuy Synthes Sales INC. | $103.90 | 2022-2024 | Xcm Biologic Tissue Matrix |
| Integra Lifesciences Corporation | $78.15 | 2022-2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $66.33 | 2025 | Collagenase Santyl |
| Astrazeneca Pharmaceuticals LP | $55.62 | 2023-2024 | Andexxa |
| Davol INC. | $50.18 | 2024-2025 | Phasix Mesh |
| Medtronic, INC. | $33.62 | 2025 | Interstim |
| Kci USA, INC. | $31.69 | 2019-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Allergan, INC. | $31.56 | 2019-2020 | |
| Lemaitre Vascular, INC. | $28.60 | 2023-2025 | Artegraft Vascular Graft |
| Inari Medical, INC. | $26.08 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Lifenet Health | $20.19 | 2024 | Theragenesis Wound Matrix |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $19.71 | 2024 | Ovitex 2s |
| Clinical Technology, INC | $18.36 | 2022 | |
| Solventum Corporation | $17.80 | 2024 | Activ.A.C., Prevena |
| Bioventus LLC | $17.17 | 2022 | |
| Abbvie INC. | $16.87 | 2022 | |
| Teleflex LLC | $13.76 | 2025 | Arrow |
| Hydrofera LLC | $12.93 | 2022 | |
| Portola Pharmaceuticals, LLC | $12.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Lam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.